Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jesus A Gonzalo Asensio, Ainhoa Arbués, Esther Pérez, Brigitte Gicquel & Carlos Martin. (2008) Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials. Expert Opinion on Biological Therapy 8:2, pages 201-211.
Read now
Read now
Marien I de Jonge, Roland Brosch, Priscille Brodin, Caroline Demangel & Stewart T Cole. (2005) Tuberculosis: from genome to vaccine. Expert Review of Vaccines 4:4, pages 541-551.
Read now
Read now
Articles from other publishers (21)
Quazim A. Alayo, Nicholas M. Provine & Pablo Penaloza-MacMaster. (2017) Novel Concepts for HIV Vaccine Vector Design. mSphere 2:6.
Crossref
Crossref
Ian M. Orme. (2013) Vaccine Development for Tuberculosis: Current Progress. Drugs 73:10, pages 1015-1024.
Crossref
Crossref
Ansar A. Pathan, Angela M. Minassian, Clare R. Sander, Rosalind Rowland, David W. Porter, Ian D. Poulton, Adrian V.S. Hill, Helen A. Fletcher & Helen McShane. (2012) Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults. Vaccine 30:38, pages 5616-5624.
Crossref
Crossref
Matthew W. Auten, Weitao Huang, Guixiang Dai & Alistair J. Ramsay. (2012) CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals. Vaccine 30:17, pages 2768-2777.
Crossref
Crossref
Stanley A. Plotkin. (2010) Correlates of Protection Induced by Vaccination. Clinical and Vaccine Immunology 17:7, pages 1055-1065.
Crossref
Crossref
Jaap T. van Dissel, Sandra M. Arend, Corine Prins, Peter Bang, Pernille Nyholm Tingskov, Karen Lingnau, Jan Nouta, Michèl R. Klein, Ida Rosenkrands, Tom H.M. Ottenhoff, Ingrid Kromann, T. Mark Doherty & Peter Andersen. (2010) Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers. Vaccine 28:20, pages 3571-3581.
Crossref
Crossref
Kandan Aravindaram, Tsun‐Yung Kuo, Chun‐Wen Lan, Hsiu‐Hui Yu, Pei‐Hsueh Wang, Yu‐San Chen, Gabriel Hsu‐Chung Chen & Ning‐Sun Yang. (2009) Protective immunity against porcine circovirus 2 in mice induced by a gene‐based combination vaccination. The Journal of Gene Medicine 11:4, pages 288-301.
Crossref
Crossref
Faramarz Dobakhti, Taraneh Naghibi, Mohammad Taghikhani, Soheila Ajdary, Ali Rafinejad, Khosrow Bayati, Shahnaz Rafiei & Morteza Rafiee-Tehrani. (2009) Adjuvanticity effect of sodium alginate on subcutaneously injected BCG in BALB/c mice. Microbes and Infection 11:2, pages 296-301.
Crossref
Crossref
Vassil St. Georgiev. 2009. National Institute of Allergy and Infectious Diseases, NIH. National Institute of Allergy and Infectious Diseases, NIH
103
124
.
Stanley A. Plotkin. (2008) Vaccines: Correlates of Vaccine‐Induced Immunity. Clinical Infectious Diseases 47:3, pages 401-409.
Crossref
Crossref
Natalie E. R. Beveridge, David A. Price, Joseph P. Casazza, Ansar A. Pathan, Clare R. Sander, Tedi E. Asher, David R. Ambrozak, Melissa L. Precopio, Phillip Scheinberg, Nicola C. Alder, Mario Roederer, Richard A. Koup, Daniel C. Douek, Adrian V. S. Hill & Helen McShane. (2007) Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctionalMycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. European Journal of Immunology 37:11, pages 3089-3100.
Crossref
Crossref
Marien I. de Jonge, Timothy P. Stinear, Stewart T. Cole & Roland Brosch. 2007. Bacterial Pathogenomics. Bacterial Pathogenomics
49
89
.
R. Chavan, K. A. Marfatia, I. C. An, D. A. Garber & M. B. Feinberg. (2006) Expression of CCL20 and Granulocyte-Macrophage Colony-Stimulating Factor, but Not Flt3-L, from Modified Vaccinia Virus Ankara Enhances Antiviral Cellular and Humoral Immune Responses. Journal of Virology 80:15, pages 7676-7687.
Crossref
Crossref
Sven Baumann, Ali Nasser Eddine & Stefan HE Kaufmann. (2006) Progress in tuberculosis vaccine development. Current Opinion in Immunology 18:4, pages 438-448.
Crossref
Crossref
Matthew G. Cottingham, Andre van Maurik, Manola Zago, Angela T. Newton, Richard J. Anderson, M. Keith Howard, Jörg Schneider & Michael A. Skinner. (2006) Different Levels of Immunogenicity of Two Strains of Fowlpox Virus as Recombinant Vaccine Vectors Eliciting T-Cell Responses in Heterologous Prime-Boost Vaccination Strategies. Clinical and Vaccine Immunology 13:7, pages 747-757.
Crossref
Crossref
Martin Vordermeier & R. Glyn Hewinson. (2006) Development of cattle TB vaccines in the UK. Veterinary Immunology and Immunopathology 112:1-2, pages 38-48.
Crossref
Crossref
Ali Nasser Eddine, Sven Baumann & Stefan H.E. Kaufmann. (2006) New tuberculosis vaccines approaching clinical trial – An overview. Drug Discovery Today: Therapeutic Strategies 3:2, pages 113-119.
Crossref
Crossref
Laleh Majlessi, Marcela Simsova, Zdenka Jarvis, Priscille Brodin, Marie-Jésus Rojas, Cécile Bauche, Clémence Nouzé, Daniel Ladant, Stewart T. Cole, Peter Sebo & Claude Leclerc. (2006) An Increase in Antimycobacterial Th1-Cell Responses by Prime-Boost Protocols of Immunization Does Not Enhance Protection against Tuberculosis. Infection and Immunity 74:4, pages 2128-2137.
Crossref
Crossref
Ian M. Orme. (2006) Preclinical testing of new vaccines for tuberculosis: A comprehensive review. Vaccine 24:1, pages 2-19.
Crossref
Crossref
H. Martin Vordermeier, Reno Pontarollo, Brenda Karvonen, Paul Cockle, Rolf Hecker, Mahavir Singh, Lorne A. Babiuk, R. Glyn Hewinson & Sylvia van Drunen Littel-van Den Hurk. (2005) Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c. Vaccine 23:35, pages 4375-4384.
Crossref
Crossref
Ian M Orme. (2005) Tuberculosis Vaccines. Drugs 65:17, pages 2437-2444.
Crossref
Crossref